Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Cancer Gene Therapy
|
March 1, 1994
Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model
E G Hanania, A B Deisseroth
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 1997
Simultaneous genetic chemoprotection of normal marrow cells and genetic chemosensitization of breast cancer cells in a mouse cancer gene therapy model
E G Hanania, A B Deisseroth
Cancer Treatment and Research
|
January 1, 1995
Genetic therapy using bone marrow transplantation
R E Giles, E G Hanania, S Fu, et al.
Cancer Gene Therapy
|
December 1, 1995
Regulation of retinoblastoma gene expression in a mouse mammary tumor model
E G Hanania, W W Au, R L Ullrich, et al.
Cancer Research
|
September 10, 1998
Improved quantitation of minimal residual disease in multiple myeloma using real-time polymerase chain reaction and plasmid-DNA complementarity determining region III standards
C J Gerard, K Olsson, R Ramanathan, et al.
Gene Therapy
|
June 1, 1995
Resistance to taxol chemotherapy produced in mouse marrow cells by safety-modified retroviruses containing a human MDR-1 transcription unit
E G Hanania, S Fu, I Roninson, et al.
Cancer Gene Therapy
|
March 1, 1995
Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells
G Hu, W Liu, E G Hanania, et al.
The American Journal of Medicine
|
November 1, 1995
Recent advances in the application of gene therapy to human disease
E G Hanania, J Kavanagh, G Hortobagyi, et al.
British Journal of Haematology
|
August 1, 1995
Transduction of MDR1 into human and mouse haemopoietic progenitor cells: use of rhodamine (Rh123) to determine transduction frequency and in vivo selection
S Hegewisch-Becker, E G Hanania, S Fu, et al.
Leukemia
|
November 11, 1999
Real-time t(11;14) and t(14;18) PCR assays provide sensitive and quantitative assessments of minimal residual disease (MRD)
K Olsson, C J Gerard, J Zehnder, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Cancer Gene Therapy
|
March 1, 1994
Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model
E G Hanania, A B Deisseroth
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 1997
Simultaneous genetic chemoprotection of normal marrow cells and genetic chemosensitization of breast cancer cells in a mouse cancer gene therapy model
E G Hanania, A B Deisseroth
Cancer Treatment and Research
|
January 1, 1995
Genetic therapy using bone marrow transplantation
R E Giles, E G Hanania, S Fu, et al.
Cancer Gene Therapy
|
December 1, 1995
Regulation of retinoblastoma gene expression in a mouse mammary tumor model
E G Hanania, W W Au, R L Ullrich, et al.
Cancer Research
|
September 10, 1998
Improved quantitation of minimal residual disease in multiple myeloma using real-time polymerase chain reaction and plasmid-DNA complementarity determining region III standards
C J Gerard, K Olsson, R Ramanathan, et al.
Gene Therapy
|
June 1, 1995
Resistance to taxol chemotherapy produced in mouse marrow cells by safety-modified retroviruses containing a human MDR-1 transcription unit
E G Hanania, S Fu, I Roninson, et al.
Cancer Gene Therapy
|
March 1, 1995
Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells
G Hu, W Liu, E G Hanania, et al.
The American Journal of Medicine
|
November 1, 1995
Recent advances in the application of gene therapy to human disease
E G Hanania, J Kavanagh, G Hortobagyi, et al.
British Journal of Haematology
|
August 1, 1995
Transduction of MDR1 into human and mouse haemopoietic progenitor cells: use of rhodamine (Rh123) to determine transduction frequency and in vivo selection
S Hegewisch-Becker, E G Hanania, S Fu, et al.
Leukemia
|
November 11, 1999
Real-time t(11;14) and t(14;18) PCR assays provide sensitive and quantitative assessments of minimal residual disease (MRD)
K Olsson, C J Gerard, J Zehnder, et al.
Page
of 2